Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

8.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Cancer Therapies02:49

Cancer Therapies

10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

655
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
655

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experimental Evidence of Caffeic Acid's Neuroprotective Activity in Alzheimer's Disease: In Vitro, In Vivo, and Delivery-Based Insights.

Medicina (Kaunas, Lithuania)·2025
Same author

Aglycone, Glycoside, or Glucuronide? Experimental and Mechanistic Insights into the Antioxidative Potential of Gossypetin, Gossypin, and Hibifolin.

The journal of physical chemistry. B·2025
Same author

<i>Salvia desoleana</i> Atzei et Picci Steam-Distillation Water By-Products as a Source of Bioactive Compounds with Antioxidant Activities.

Foods (Basel, Switzerland)·2025
Same author

The Role of Rosmarinic Acid in Cancer Prevention and Therapy: Mechanisms of Antioxidant and Anticancer Activity.

Antioxidants (Basel, Switzerland)·2024
Same author

Ultra-low reflection of sub-THz waves in graphene-based composite with metasurface for stealth technology.

Optics express·2024
Same author

Quality of education and mental health of pharmacy students in Poland.

Advances in clinical and experimental medicine : official organ Wroclaw Medical University·2024

Related Experiment Video

Updated: Feb 17, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K

Insights into novel anticancer applications for apigenin.

Adam Kowalczyk1, Agnieszka Bodalska2, Marta Miranowicz3

  • 1Department of Pharmacognosy, Wroclaw Medical University, Poland.

Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University
|December 7, 2017
PubMed
Summary

Apigenin, a natural flavonoid found in fruits and vegetables, shows potential anticancer properties by inhibiting cancer cell glucose uptake and tumor growth. Further research is needed to fully understand its mechanisms against various cancers.

Keywords:
anticancer agentapigeninchemopreventionflavonoids

More Related Videos

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.4K

Related Experiment Videos

Last Updated: Feb 17, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.4K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Flavonoids are natural plant compounds, with apigenin (C₁₅H₁₀O⁵) being a notable example found in various fruits, vegetables, and medicinal herbs.
  • Apigenin is recognized for its anti-inflammatory and antioxidant activities.
  • Emerging research highlights apigenin's potential as a bioactive substance with anticancer properties.

Purpose of the Study:

  • To review and summarize the reported anticancer properties of apigenin based on recent literature.
  • To explore the mechanisms by which apigenin may exert its anticancer effects.
  • To identify areas for future research regarding apigenin's role in cancer prevention and treatment.

Main Methods:

  • Literature review of scientific articles and research data on apigenin and cancer.
  • Analysis of studies investigating apigenin's effects on cancer cell behavior and tumor development.
  • Synthesis of findings related to apigenin's molecular mechanisms.

Main Results:

  • Apigenin has demonstrated the ability to reduce glucose uptake in cancer cells.
  • It inhibits the remodeling of the extracellular matrix, crucial for cancer progression.
  • Apigenin hinders the function of cell adhesion molecules and inhibits angiogenesis (tumor blood vessel development).

Conclusions:

  • Apigenin exhibits a broad spectrum of potential anticancer activities, suggesting protective effects against various cancer types.
  • The precise mechanisms underlying apigenin's anticancer effects are still under investigation.
  • Further research is warranted to fully elucidate apigenin's therapeutic potential in oncology.